Published in Transl Psychiatry on December 01, 2015
Sequenced Treatment Alternatives to Relieve Depression (STAR*D) | NCT00021528
Genetic Contributions of Inflammation to Depression. Neuropsychopharmacology (2016) 0.79
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods (2007) 50.83
Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods (2009) 18.51
A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am J Hum Genet (2009) 17.80
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
Annotation of functional variation in personal genomes using RegulomeDB. Genome Res (2012) 11.47
Placebo response in studies of major depression: variable, substantial, and growing. JAMA (2002) 7.56
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience (2015) 5.06
Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell (2010) 4.45
Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities. Genome Res (2010) 3.46
A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry (2010) 2.77
DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet (2009) 2.56
When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry (1997) 2.35
Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci (2014) 2.23
Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull (2001) 1.97
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry (2005) 1.76
Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry (2014) 1.54
Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 1.52
The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology (2011) 1.52
GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood (2010) 1.40
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry (2008) 1.38
Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol Psychiatry (2004) 1.36
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study. Neuropsychopharmacology (2008) 1.29
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet (2010) 1.26
Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry (2007) 1.23
The STAR*D study: treating depression in the real world. Cleve Clin J Med (2008) 1.20
Gene expression studies in major depression. Curr Psychiatry Rep (2010) 1.17
Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res (2014) 1.17
On the outside, looking in: a review and evaluation of the comparability of blood and brain "-omes". Am J Med Genet B Neuropsychiatr Genet (2013) 1.13
What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet (2008) 1.11
The role of immune genes in the association between depression and inflammation: a review of recent clinical studies. Brain Behav Immun (2012) 1.03
Primary skin fibroblasts as a model of Parkinson's disease. Mol Neurobiol (2012) 1.01
Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biol Psychiatry (2013) 0.98
In vitro modulation of the glucocorticoid receptor by antidepressants. Stress (2008) 0.98
Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. J Affect Disord (2012) 0.98
Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry (2013) 0.93
Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood. Am J Med Genet B Neuropsychiatr Genet (2010) 0.93
The Immunoproteasome Cleans up after Inflammation. Cell (2010) 0.92
Risk factors for anxiety disorders: common and specific effects in a national sample. Depress Anxiety (2014) 0.91
Pathway analysis of a genome-wide association study in schizophrenia. Gene (2013) 0.90
Genetics of proteasome diseases. Scientifica (Cairo) (2013) 0.90
Decreased serotonin 5-HT2A receptor-stimulated phosphoinositide signaling in fibroblasts from melancholic depressed patients. Neuropsychopharmacology (2004) 0.85
Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts. Exp Cell Res (2013) 0.82
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One (2015) 0.82
Prevalence of treatment-resistant depression in primary care: cross-sectional data. Br J Gen Pract (2013) 0.80
Proteasome modulator 9 gene SNPs, responsible for anti-depressant response, are in linkage with generalized anxiety disorder. J Cell Physiol (2014) 0.78
Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.78
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder. J Affect Disord (2015) 0.76